Tokyo Tape
Sign in
← Medinet

Quarterly report · Q1

2370.TEDINET S100Q5ZZ
Period2022-10-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥185m2022-10-01 → 2022-12-31StandaloneNet sales
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales (5-year summary)
Revenue¥173m2021-10-01 → 2021-12-31StandaloneNet sales
Operating income−¥325m2022-10-01 → 2022-12-31StandaloneOperating income
Operating income−¥340m2021-10-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥324m2022-10-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥341m2021-10-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥324m2022-10-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥341m2021-10-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥326m2022-10-01 → 2022-12-31StandaloneProfit loss
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneNet income loss (5-year summary)
Net income−¥342m2021-10-01 → 2021-12-31StandaloneProfit loss
Total assets¥5.5bnat 2022-12-31StandaloneAssets
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥5.5bnat 2021-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥448mat 2022-12-31StandaloneLiabilities
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Net assets / equity¥5.0bnat 2022-12-31StandaloneNet assets
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥5.0bnat 2021-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥4.1bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
EPS (basic)¥-1.542022-10-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.882021-10-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio91.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued211,730,423at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued184,950,423at 2021-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥161m
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2022-10-01 → 2022-12-31¥158,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2022-10-01 → 2022-12-31¥158,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥107m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2022-10-01 → 2022-12-31¥185m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2022-10-01 → 2022-12-31¥185m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥57m
—segment totalrevenue2022-10-01 → 2022-12-31¥185m
—segment totalrevenue external2022-10-01 → 2022-12-31¥185m
—segment totalsegment profit2022-10-01 → 2022-12-31−¥164m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2021-12-31−¥135m
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2021-12-31¥47,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2021-12-31¥47,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2021-12-31−¥157m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2021-12-31¥173m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2021-12-31¥173m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2021-12-31−¥47m
—segment totalrevenue2021-10-01 → 2021-12-31¥173m
—segment totalrevenue external2021-10-01 → 2021-12-31¥173m
—segment totalsegment profit2021-10-01 → 2021-12-31−¥205m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 299
ItemContextValueUnit
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember10571000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember57016000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember29051000JPY
Other clPrior1YearInstant_NonConsolidatedMember147408000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember121650000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember279313000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember213616000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember156160000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember156654000JPY
Other nclPrior1YearInstant_NonConsolidatedMember130662000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember78080000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember286822000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember234735000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember566136000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember448352000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember5892020000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember5892020000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember1360593000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember1360593000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-2093633000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-2419154000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-2000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-2000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember5158978000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember4833457000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember352946000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember209092000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember352946000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember209092000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember5511924000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember5042549000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember6078061000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember5490901000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember172854000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember185153000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember133024000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember138904000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember39830000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember46248000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember379562000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember371747000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-339731000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-325498000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember1688000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember1719000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration_NonConsolidatedMember1250000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration_NonConsolidatedMember1550000JPY
Income for cancellation of manufacturing noiPrior1YTDDuration_NonConsolidatedMember2391000JPY
Income for cancellation of manufacturing noiCurrentYTDDuration_NonConsolidatedMember2275000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember335000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-10-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass